https://www.selleckchem.com/pr....oducts/syrosingopine
Molybdenum dioxide-gadolinium-arginine/glycine/aspartic acid (MoS₂-Gd-RGD) sequences targeting nano-contrast agents that specifically bind to human hepatocellular carcinoma (HCC) HepG₂ cells were synthesized, and their targeting imaging effects on HCC cells and models were evaluated. Zeta potential, particle size and Fourier Transform Infrared Spectrometer (FTIR) were used to characterize the nano-contrast agent, and its cytotoxicity was evaluated. The MoS₂-Gd nanoparticles were used as control in vitro to determine the ta
Like
Comment
Share
